Clinical Trials Browser

OTHER × Recurrence × Epirubicin × Clear all

NCT05146635 2022-01-11

Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial

Phase NA Unknown

Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT02631499 2015-12-22

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Recurrence